[{"orgOrder":0,"company":"WinSanTor","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases | Eastern Virginia Medical School","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Miscellaneous","year":"2021","type":"Inapplicable","leadProduct":"Pirenzepine","moa":"Muscarinic acetylcholine receptor M1","graph1":"Neurology","graph2":"Phase II","graph3":"WinSanTor","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"WinSanTor \/ National Institute of Diabetes and Digestive and Kidney Diseases | Eastern Virginia Medical School","highestDevelopmentStatusID":"8","companyTruncated":"WinSanTor \/ National Institute of Diabetes and Digestive and Kidney Diseases | Eastern Virginia Medical School"},{"orgOrder":0,"company":"WinSanTor","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"WST-057","moa":"Muscarinic acetylcholine receptor M1 (CHRM1)","graph1":"Neurology","graph2":"Phase II","graph3":"WinSanTor","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Solution","sponsorNew":"WinSanTor \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"WinSanTor \/ Undisclosed"},{"orgOrder":0,"company":"WinSanTor","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"WST-057","moa":"Muscarinic acetylcholine receptor M1 (CHRM1)","graph1":"Neurology","graph2":"Phase II","graph3":"WinSanTor","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Solution","sponsorNew":"WinSanTor \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"WinSanTor \/ Undisclosed"}]